Results of the Pivotal STORM Study (Part 2) in Penta-Refractory Multiple Myeloma (MM): Deep and Durable Responses with Oral Selinexor Plus Low Dose Dexamethasone in Patients with Penta-Refractory MM
Conclusions: Results of the pivotal STORM Part 2 in penta (PI, IMiD, dara)-refractory MM demonstrated that oral selinexor plus low-dose dexamethasone (Sd) was highly active with an ORR of 26.2%. Importantly, responses were rapid and deep with 2 patients achieving sCRs (both MRD negative) in these heavily pre-treated penta-refractory MM pts (median 7 prior regimens, 53% high risk). AEs are a function of dose/schedule/disease severity and can be managed with dose modifications and supportive care. No major organ toxicity was observed and AEs were typically transient and reversible. Sd is an all-oral, first in class mechanism with novel MOA and represents a potential therapeutic option to the growing number of pts with penta-refractory MM who have exhausted approved therapies.DisclosuresChari: Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Adaptive Biotechnology: Membership on an entity's Board of Directors or advisory committees; The Binding Site: Consultancy; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees; Array Biopharma: Research Funding; Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Pharmacyclics: Research Funding; Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees, Res...
Source: Blood - Category: Hematology Authors: Chari, A., Vogl, D. T., Dimopoulos, M. A., Nooka, A. K., Huff, C. A., Moreau, P., Cole, C. E., Richter, J., Dingli, D., Vij, R., Tuchman, S. A., Raab, M. S., Weisel, K., Delforge, M., Kaminetzky, D., Cornell, R. F., Stewart, A. K., Hoffman, J., Godby, K. Tags: 653. Myeloma: Therapy, excluding Transplantation: Antibodies and Targeted Therapies Source Type: research
More News: Anemia | Anorexia | Biotechnology | Cancer | Cancer & Oncology | Databases & Libraries | Dexamethasone | Eating Disorders & Weight Management | Employment | Genetics | Merck | Myeloma | Oral Cancer | Pharmaceuticals | Pulmonary Thromboembolism | Respiratory Medicine | Revlimid | Sint Maarten Health | Stem Cell Therapy | Stem Cells | Study | Thrombocytopenia | Toxicology | Transplants | Velcade | Weight Loss